Humatica advises Capvis on their recent investment in AMANN GIRRBACH
By Humatica
Humatica AG was retained to advise Capvis on its majority investment in Austrian firm AMANN GIRRBACH AG, a pioneer in dental CAD/CAM technology. The firm is a leading innovator in the field and a full-service provider for digital dental prosthetics.
Humatica provided organisational due diligence services for this transaction.
To view press release: Humatica advises Capvis on their recent investment in AMANN GIRRBACH
Related News
Humatica announces promotions in London
Humatica announces promotions in London office Humatica is pleased to announce three promotions in its London office. Carlo Raco has been promoted to Director, Juan…
Read more
Humatica announces senior promotions in London and Zurich
Humatica is pleased to announce two senior level promotions, reflecting continued growth and the strengthening of its leadership team. Paul Simpson, based in Zurich, has…
Read more
Humatica once again recognised as a leader in private equity value creation by Actum in its 2026 awards
Humatica has once again been short-listed for Actum’s 2026 Value Creation Award in the People & Organisational Strategy category. This recognition reflects Humatica’s 23‑year commitment…
Read more